Cargando…

Treatment Options for Hepatitis A and E: A Non-Systematic Review

Hepatitis A and hepatitis E are relatively common causes of liver disease. Both viruses are mainly transmitted through the faecal–oral route and, consequently, most outbreaks occur in countries with poor sanitation. An important role of the immune response as the driver of liver injury is also share...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gabrielli, Filippo, Alberti, Francesco, Russo, Cristina, Cursaro, Carmela, Seferi, Hajrie, Margotti, Marzia, Andreone, Pietro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10221699/ https://www.ncbi.nlm.nih.gov/pubmed/37243166 http://dx.doi.org/10.3390/v15051080

Ejemplares similares

Virological Treatment Monitoring for Chronic Hepatitis B
por: Loggi, Elisabetta, et al.
Publicado: (2022)

Secondary Sclerosing Cholangitis After SARS-CoV2: ICU Ketamine Use or Virus-Specific Biliary Tropism and Injury in the Context of Biliary Ischemia in Critically Ill Patients?
por: Bartoli, Alessandra, et al.
Publicado: (2023)

Treatments for HBV: A Glimpse into the Future
por: Bartoli, Alessandra, et al.
Publicado: (2021)

Severe acute respiratory syndrome coronavirus-2-associated cholangiopathies
por: Bartoli, Alessandra, et al.
Publicado: (2022)

Primary biliary cholangitis associated with SARS-CoV-2 infection
por: Bartoli, Alessandra, et al.
Publicado: (2021)

COVID-19 treatment options: a difficult journey between failed attempts and experimental drugs
por: Bartoli, Alessandra, et al.
Publicado: (2021)

Investigating Acute Hepatitis after SARS-CoV-2 Vaccination or Infection: A Genetic Case Series
por: Bernasconi, Elisa, et al.
Publicado: (2023)

Virus-Specific Immune Response in HBeAg-Negative Chronic Hepatitis B: Relationship with Clinical Profile and HBsAg Serum Levels
por: Loggi, Elisabetta, et al.
Publicado: (2013)

Vitamin E for the treatment of children with hepatitis B e antigen-positive chronic hepatitis: A systematic review and meta-analysis
por: Fiorino, Sirio, et al.
Publicado: (2017)

Monitoring the treatment of hepatitis C with directly acting antivirals by serological and molecular methods
por: Loggi, Elisabetta, et al.
Publicado: (2017)

Efficacy and Safety of Daclatasvir in Hepatitis C: An Overview
por: Gamal, Nesrine, et al.
Publicado: (2016)

Update on Alcohol and Viral Hepatitis
por: Gitto, Stefano, et al.
Publicado: (2014)

The carotid sheath route: An option to approach retrocarotid prespinal tumors with paravertebral extension
por: Gagliardi, Filippo, et al.
Publicado: (2023)

Management of hepatic epithelioid haemangio-endothelioma in children: what option?
por: Sharif, K, et al.
Publicado: (2004)

Treatment Options for MODY Patients: A Systematic Review of Literature
por: Delvecchio, Maurizio, et al.
Publicado: (2020)

Silymarin: An option to treat non-alcoholic fatty liver disease
por: Colica, Carmela, et al.
Publicado: (2017)

Study of the Serum Metabolomic Profile in Nonalcoholic Fatty Liver Disease: Research and Clinical Perspectives
por: Gitto, Stefano, et al.
Publicado: (2018)

Stage III Non-Small-Cell Lung Cancer: An Overview of Treatment Options
por: Petrella, Francesco, et al.
Publicado: (2023)

Liver grafts from hepatitis B surface antigen-positive donors: A review of the literature
por: Loggi, Elisabetta, et al.
Publicado: (2016)

Endpoints and New Options for Treatment of Chronic Hepatitis D
por: Lok, Anna S., et al.
Publicado: (2021)

Optimization of the e-e- Option for the ILC
por: Alabau-Pons, M, et al.
Publicado: (2006)

Optimization of the e-e- option for the ILC
por: Pons, M A, et al.
Publicado: (2006)

LHC e-p option
por: Keil, Eberhard
Publicado: (1997)

Association of Nonalcoholic Fatty Liver Disease (NAFLD) with Peripheral Diabetic Polyneuropathy: A Systematic Review and Meta-Analysis
por: Greco, Carla, et al.
Publicado: (2021)

Superficial temporal artery pseudoaneurysm presenting as a growing, pulsatile, and tender mass
por: Seferi, Arsen, et al.
Publicado: (2016)

Electrons in the VLHC tunnels: the $e^{+}e^{-}$ and ep options
por: Norem, J, et al.
Publicado: (1999)

Hepatic Encephalopathy: An Update on the Pathophysiology and Therapeutic Options
por: Elwir, Saleh, et al.
Publicado: (2017)

Autoimmune Hepatitis: Treatment Options and Management Review
por: Gadour, Eyad
Publicado: (2021)

SGLT2 Inhibitors: A Broad Impact Therapeutic Option for the Nephrologist
por: Granata, Antonio, et al.
Publicado: (2022)

Case Study of a Spinal Epidural Capillary Hemangioma: A 4-Year Postoperative Follow-Up
por: Seferi, Arsen, et al.
Publicado: (2013)

Pharmacotherapeutic Options for Managing Neuropathic Pain: A Systematic Review and Meta-Analysis
por: Di Stefano, Giulia, et al.
Publicado: (2021)

$e^{+}e^{-}$ and ep options for the Very Large Hadron Collider
por: Norem, J
Publicado: (1998)

Current treatment options for psoriatic arthritis: spotlight on abatacept
por: Ursini, Francesco, et al.
Publicado: (2018)

Acute non-A, non-B, non-C hepatitis differences and similarities between hepatitis E virus infection and autoimmune hepatitis, with phylogenetic analysis of hepatitis E virus in humans and wild boars
por: Zachou, Kalliopi, et al.
Publicado: (2022)

A Review on Extrahepatic Manifestations of Chronic Hepatitis C Virus Infection and the Impact of Direct-Acting Antiviral Therapy
por: Mazzaro, Cesare, et al.
Publicado: (2021)

A Systematic Review of the Extra-Hepatic Manifestations of Hepatitis E Virus Infection
por: Rawla, Prashanth, et al.
Publicado: (2020)

Hepatitis E Infection in Nigeria: A Systematic Review
por: Okagbue, Hilary I., et al.
Publicado: (2019)

New Therapeutic Options for the Treatment of Sickle Cell Disease
por: Matte, Alessandro, et al.
Publicado: (2019)

Physics at a gamma gamma, e gamma and e-e- Option for a Linear Collider
por: de Roeck, A
Publicado: (2003)

Emerging therapeutic options for non-alcoholic fatty liver disease: A systematic review
por: Tidwell, Jasmine, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_2p9jdjsq5pqbqb4iongj2761al